Identification of new genes involved in muscle disorders has dramatically c
hanged the traditional clinical classification of the large and heterogeneo
us group of the muscular dystrophies. Results obtained in recent years by p
ositional candidate cloning have demonstrated the role of the sarcolemma an
d of the nuclear envelope in normal muscle function and have elucidated mol
ecular pathways perturbed by mutations that lead to muscular dystrophy.